Lenshil - Lenvatinib 4mg 10 Capsules (Lenvima) - Anticancer Medication

LENVATINIB 4 mg (Lenshil) x 10 Capsules

~~$90.00~~ $40.00

Prescription Required

Lenshil contains Lenvatinib 4mg, a targeted cancer medicine used in the treatment of thyroid cancer, kidney cancer (renal cell carcinoma), and liver cancer (hepatocellular carcinoma).

Generic Name	Lenvatinib
Manufacturer	Shilpa Medicare Ltd
Packing	10 Capsules
Prescribed For	Thyroid Cancer, Kidney Cancer, Liver Cancer
Availability	In Stock
Shipping to	USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, Japan, UAE, Saudi Arabia, Qatar, Kuwait, Georgia, Mexico, and many other countries.

Genuine Medicines

Quick Air Delivery

Secure Payment

24/7 Support

Benefits of LENVATINIB 4 mg

Helps treat certain types of cancer
Targets and slows tumor growth
Supports targeted cancer therapy
Used in thyroid, liver, and kidney cancer treatment
Helps reduce cancer progression
May improve treatment outcomes

Side Effects

High blood pressure (Hypertension)
Fatigue or weakness
Diarrhea
Nausea and vomiting
Loss of appetite
Weight loss
Mouth sores (stomatitis)
Muscle or joint pain
Swelling in hands, feet, or face
Rash or dry skin

Caution

Take exactly as prescribed.
Do not skip or stop doses.
Inform your doctor of heart, liver, or kidney problems.
Monitor blood pressure and liver function regularly.
Do not share medication.

Lenvatinib Price and Reimbursement Information by Country

Lenvatinib prices may vary between countries depending on the brand, dosage form, strength, pack size, pharmacy, insurance coverage, government subsidies, taxes and local healthcare policies. The following resources provide country-specific pricing, reimbursement or medicine information.

View Lenvatinib medicinal-form and pricing information on NICE BNF (UK) – https://bnf.nice.org.uk/
View Lenvima (lenvatinib) pricing information on Drugs.com (USA) – https://www.drugs.com/
View Lenvatinib subsidy and price information on PBS (Australia) – https://www.pbs.gov.au/
View Lenvatinib subsidy and medicine information on Singapore’s National Drug Formulary – https://www.ndf.gov.sg/
View Lenvatinib brand and medicine information on Farmaco (UAE) – https://farmacoinc.com/
View Lenvatinib reimbursement information at Canada’s Drug Agency – https://www.cda-amc.ca/

Author

Reviewed By

Dr. Abhinav Narang

Doctor of Medicine (MD) | Professional Interest in Oncology

Dr. Abhinav Narang holds a Doctor of Medicine (MD) degree and has a professional interest in oncology and cancer care. His interests include anticancer therapies, monitoring treatment response, managing treatment-related side effects and providing supportive care throughout the patient’s treatment journey.

Disclaimer

This website operates in compliance with applicable pharmaceutical laws. All content and data available on this website are intended solely for informational purposes. The information provided is not a substitute for professional medical advice, diagnosis, or treatment. Information provided here is for general awareness and does not replace medical advice. We strongly encourage you to consult a qualified healthcare professional for guidance.